Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

NVTA | Invitae Corp

Healthcare | Diagnostics & Research | USA | NYSE

Index	RUT	P/E	-	EPS (ttm)	-3.23	Insider Own	2.22%	Shs Outstand	267.01M	Perf Week	-12.75%
Market Cap	179.52M	Forward P/E	-	EPS next Y	-1.04	Insider Trans	-2.91%	Shs Float	261.08M	Perf Month	-22.28%
Income	-799.67M	PEG	-	EPS next Q	-0.31	Inst Own	61.61%	Short Float / Ratio	15.06% / 3.98	Perf Quarter	-38.88%
Sales	493.88M	P/S	0.36	EPS this Y	39.55%	Inst Trans	-9.47%	Short Interest	39.31M	Perf Half Y	-47.88%
Book/sh	-0.75	P/B	-	EPS next Y	21.47%	ROA	-41.94%	Target Price	2.03	Perf Year	-73.74%
Cash/sh	1.22	P/C	0.55	EPS next 5Y	17.01%	ROE	-863.95%	52W Range	0.67 - 3.78	Perf YTD	-63.85%
Dividend	-	P/FCF	-	EPS past 5Y	-37.83%	ROI	-58.77%	52W High	-82.19%	Beta	1.75
Dividend %	-	Quick Ratio	2.83	Sales past 5Y	53.81%	Gross Margin	21.92%	52W Low	0.35%	ATR	0.07
Employees	1700	Current Ratio	2.97	Sales Q/Q	-11.78%	Oper. Margin	-113.39%	RSI (14)	29.50	Volatility	5.99% 9.72%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	92.80%	Profit Margin	-161.92%	Rel Volume	1.41	Prev Close	0.67
Shortable	Yes	LT Debt/Eq	-	Earnings	Aug 08 AMC	Payout	-	Avg Volume	9.89M	Price	0.67
Recom	3.91	SMA20	-19.82%	SMA50	-36.51%	SMA200	-55.15%	Volume	6,118,080	Change	0.35%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-05-23	Resumed	JP Morgan	Underweight
May-15-23	Downgrade	Raymond James	Mkt Perform → Underperform
Jan-31-23	Downgrade	Goldman	Neutral → Sell	$2
Aug-25-22	Initiated	Credit Suisse	Underperform	$1
Aug-10-22	Downgrade	JP Morgan	Neutral → Underweight
Jul-26-22	Downgrade	Cowen	Outperform → Market Perform	$8 → $2.50
Jul-21-22	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-20-22	Downgrade	Ladenburg Thalmann	Buy → Neutral
Jul-19-22	Downgrade	The Benchmark Company	Buy → Hold
Jul-19-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
Jun-03-22	Initiated	Piper Sandler	Underweight	$2.50
Aug-04-21	Upgrade	The Benchmark Company	Hold → Buy	$35
Jun-15-21	Initiated	Raymond James	Outperform	$37
Jun-03-21	Initiated	Goldman	Neutral	$33
May-25-21	Initiated	Wells Fargo	Equal Weight	$30
Apr-05-21	Upgrade	Oppenheimer	Perform → Outperform	$48
Feb-18-21	Upgrade	Ladenburg Thalmann	Neutral → Buy	$46.50 → $58
Feb-01-21	Downgrade	Oppenheimer	Outperform → Perform
Oct-14-20	Downgrade	JP Morgan	Overweight → Neutral
Sep-09-20	Initiated	Morgan Stanley	Equal-Weight	$38

Show Previous Ratings

Sep-22-23 04:30PM	Invitae Receives Notice of Non-Compliance with NYSE Minimum Share Price Continued Listing Standard (PR Newswire)
01:08PM	Invitae aims to regain NYSE compliance after average share price falls below $1 (Investing.com)
Sep-21-23 05:00AM	Invitae Stock Analysis: Buy, Sell, or Hold? (Motley Fool)
Sep-19-23 01:13PM	Novavax and Invitae implement cost-cutting measures amid financial challenges (Investing.com)
Sep-14-23 02:00PM	Cathie Wood Is Betting on This Struggling Stock. Should You? (Motley Fool)
09:37AM	Loading…
Aug-30-23 09:37AM	Cathie Wood Just Sold Nvidia -- and Bought These 5 Potentially Explosive Growth Stocks Again (Motley Fool) +6.74%
Aug-28-23 04:02PM	Invitae Hires Industry Veteran Robert Guigley as Chief Commercial Officer (PR Newswire) -5.91%
Aug-24-23 12:33PM	Why Invitae Stock Is Crashing Today (Motley Fool) -14.35%
Aug-15-23 07:30AM	Clinical Trial Results Support Genetic Testing of All Patients with Prostate Cancer (PR Newswire) -5.41%
Aug-14-23 04:02PM	Invitae Announces Selection of Finance Executive Robert Dickey as Interim CFO (PR Newswire)
Aug-11-23 08:00AM	Down 96%, Is Invitae Stock a Buy? (Motley Fool)
Aug-09-23 02:00AM	Invitae (NVTA) Q2 2023 Earnings Call Transcript (Motley Fool) -7.50%
Aug-08-23 05:50PM	Invitae (NVTA) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:40PM	Invitae: Q2 Earnings Snapshot (AP Finance)
04:01PM	Invitae Reports Second Quarter 2023 Financial Results (PR Newswire)
04:45AM	Loading…
Jul-28-23 04:45AM	Best Beaten-Down Growth Stock to Buy: Nano Dimension vs. Invitae (Motley Fool) +7.58%
Jul-26-23 04:01PM	Invitae to Announce Second Quarter 2023 Financial Results on Tuesday, August 8, 2023 (PR Newswire) +13.39%
05:13AM	Down 97%, Is It Finally Time to Buy Invitae Stock? (Motley Fool)
Jul-21-23 12:00PM	Invitae (NVTA) Upgraded to Buy: Here's Why (Zacks)
Jun-26-23 05:30AM	Better Recovery-Story Buy: Emergent BioSolutions or Invitae? (Motley Fool)
Jun-14-23 11:40AM	10 DNA Stocks Billionaires Are Loading Up On (Insider Monkey) -8.45%
Jun-08-23 06:19AM	Invitae Corporation (NYSE:NVTA) Stock's 27% Dive Might Signal An Opportunity But It Requires Some Scrutiny (Simply Wall St.)
Jun-05-23 02:00PM	Wall Street Says These 2 Stocks May Double. Should You Buy Them? (Motley Fool)
May-31-23 06:59AM	Invitae to Present at the William Blair 43rd Annual Growth Stock Conference (PR Newswire)
May-26-23 08:01AM	New Research Insights to be Presented by Invitae at the 2023 ASCO Annual Meeting Reinforce the Critical Role of Germline Genetic Testing in Oncology (PR Newswire)
May-25-23 07:00PM	Invitae Announces CFO Transition and Selection of Veteran Finance Executive Christine Gorjanc as Interim CFO (PR Newswire) -6.09%
May-15-23 04:27PM	Natera wins $19 million US verdict from ArcherDX in cancer-detection patent case (Reuters) -9.35%
04:24PM	Natera wins $19 mln US verdict from ArcherDX in cancer-detection patent case (Reuters)
04:07PM	Invitae to Appeal Trial Verdict (PR Newswire)
May-11-23 02:01PM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
08:30PM	Loading…
May-09-23 08:30PM	Invitae (NVTA) Q1 2023 Earnings Call Transcript (Motley Fool)
05:35PM	Invitae (NVTA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Invitae Reports First Quarter 2023 Financial Results (PR Newswire)
Apr-26-23 06:59AM	Invitae to Announce First Quarter 2023 Financial Results on Tuesday, May 9, 2023 (PR Newswire)
Apr-21-23 09:52PM	Why Shares of Invitae Soared on Friday (Motley Fool) +11.57%
Apr-17-23 04:30PM	Invitae Publishes Annual Environmental, Social and Governance (ESG) Report (PR Newswire)
Apr-13-23 08:45AM	New Study Findings Published in Nature Show Circulating Tumor DNA (ctDNA) Can Predict and Detect Cancer Recurrence Earlier In Non-Small Cell Lung Cancer (PR Newswire) +9.16%
Mar-28-23 10:10AM	Invitae Corporation (NYSE:NVTA) is a favorite amongst institutional investors who own 68% (Simply Wall St.)
Mar-22-23 07:30AM	Invitae and Deerfield Management Partner to Create Novel Therapeutics for Rare Diseases (PR Newswire) -6.06%
Mar-21-23 07:30AM	Invitae Announces Partnership with Epic to Streamline Genetic Testing (PR Newswire) +9.09%
Mar-16-23 07:30AM	Invitae Appoints Dr. W. Michael Korn as Chief Medical Officer for Oncology (PR Newswire)
Mar-15-23 05:30PM	Invitae to Present Data at The American Clinical Genetics Meeting 2023 That Supports Removing Barriers to Genetic Testing (PR Newswire)
Mar-06-23 07:30AM	Invitae's PCM Assay for Minimal Residual Disease Receives its First Commercial Coverage (PR Newswire) -9.19%
Mar-01-23 04:05PM	Invitae to Present at the TD Cowen 43rd Annual Health Care Conference (PR Newswire) -21.86%
Feb-28-23 11:00PM	Invitae (NVTA) Q4 2022 Earnings Call Transcript (Motley Fool) +6.44%
07:35PM	Invitae (NVTA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:15PM	Invitae Announces Convertible Notes and Share Exchange and New Convertible Notes Issuance (PR Newswire)
04:10PM	Invitae Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Company Updates (PR Newswire)
Feb-23-23 10:07AM	Down 78% in 1 Year, Is There Any Hope Left for Invitae? (Motley Fool)
Feb-16-23 07:00AM	If You Invested $10,000 in Invitae in 2018, This Is How Much You Would Have Today (Motley Fool)
Feb-14-23 07:00AM	Invitae to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023 (PR Newswire)
Feb-13-23 01:59PM	The 7 Best Stocks to Short This Week (InvestorPlace)
Feb-09-23 08:15AM	Is It Too Late to Buy Invitae Stock? (Motley Fool)
Feb-08-23 08:53AM	Invitae Stock: Approach With Caution (Motley Fool) -6.05%
Feb-03-23 01:19PM	10 Hot Healthcare Stocks To Buy Now (Insider Monkey)
Jan-30-23 07:30AM	Invitae Appoints William H. Osborne to its Board of Directors (PR Newswire)
Jan-19-23 11:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool) -6.20%
Jan-12-23 11:03AM	Invitae cut 1,000 jobs. Here's this new CEO's reset plan. (American City Business Journals)
Jan-09-23 07:00AM	Invitae Reports Preliminary 2022 Financial Results (PR Newswire) +6.53%
Jan-04-23 08:41AM	3 Growth Stocks That Haven't Been This Cheap in Years (Motley Fool)
07:30AM	Invitae to Present at the 41st Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-21-22 06:05AM	The one-year earnings decline has likely contributed toInvitae's (NYSE:NVTA) shareholders losses of 89% over that period (Simply Wall St.)
Dec-20-22 07:30AM	Invitae Completes Selected Assets Sale of its Next Generation Sequencing (NGS) research assays to Integrated DNA Technologies, Inc. (PR Newswire) -7.14%
Dec-19-22 05:15PM	Invitae Executive Appointed to National Health Information Technology Advisory Committee (PR Newswire) -7.11%
Dec-17-22 06:30AM	Invitae Stock: Bull vs. Bear (Motley Fool)
Dec-16-22 04:00PM	Which Is the Better Buy: Vertex or Invitae? (Motley Fool)
Dec-07-22 07:30AM	Invitae Releases Data Use Transparency Report, Demonstrating the Impact of Patient Data on Genetic Research (PR Newswire)
Dec-05-22 03:49PM	13 Best Genomics Stocks To Buy Now (Insider Monkey)
Dec-01-22 07:30AM	Invitae Launches Rare Patient Network for Pediatric Patients With Rare Neurodevelopmental Diseases (PR Newswire)
Nov-29-22 10:07AM	Is Invitae in Danger of Running Out of Money? (Motley Fool)
Nov-15-22 08:11PM	Why Shares of Invitae Rose 11% on Tuesday (Motley Fool) +11.04%
Nov-12-22 06:00AM	More Likely to 5X First: Teladoc vs. Invitae (Motley Fool)
Nov-10-22 10:13AM	Invitae Showcases Advances in Medical Genomics at the National Society of Genetic Counselors (NSGC) 41st Annual Conference (PR Newswire) +36.40%
05:54AM	Invitae Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Nov-09-22 11:30AM	Why Invitae Stock Is Crushing It Today (Motley Fool)
Nov-08-22 09:00PM	Invitae (NVTA) Q3 2022 Earnings Call Transcript (Motley Fool)
05:55PM	Invitae (NVTA) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Invitae Reports Third Quarter 2022 Financial Results (PR Newswire)
Nov-05-22 09:45AM	Could Invitae Stock Help You Retire a Millionaire? (Motley Fool)
Nov-03-22 05:15PM	Schrodinger, Inc. (SDGR) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -6.69%
Oct-31-22 05:13PM	Invitae study shows therapy informed by genetic testing reduces seizures in some patients with epilepsy (PR Newswire) +9.32%
Oct-30-22 08:00AM	Can Invitae Deliver a Positive Surprise? (TheStreet.com)
Oct-28-22 11:16AM	Invitae to Present Data at the American Society of Human Genetics Annual Meeting Furthering the Understanding of Variants of Uncertain Significance in Underrepresented Populations (PR Newswire)
09:33AM	Why Invitae Stock Was So Healthy This Week (Motley Fool)
06:30AM	Is Invitae Stock a Buy Now? (Motley Fool)
Oct-27-22 07:30AM	Invitae Announces Partnership for Real-World Data Sharing to Inform Rare Cancer Research (PR Newswire) -8.06%
Oct-25-22 04:05PM	Invitae to Announce Third Quarter 2022 Financial Results on Tuesday, November 8, 2022 (PR Newswire) +10.14%
Oct-19-22 09:55AM	With 83% ownership of the shares, Invitae Corporation (NYSE:NVTA) is heavily dominated by institutional owners (Simply Wall St.) -7.24%
Oct-03-22 11:43AM	Would Exact Sciences Acquire Invitae? Unlikely. (TheStreet.com)
Sep-27-22 07:30AM	Invitae Appointed to National Quality Forum Committee on Quality Standards for Healthcare (PR Newswire)
Sep-23-22 02:35PM	Why Invitae Corporation Sank as Much as 25.5% This Week (Motley Fool)
Sep-22-22 11:00AM	Clinical Practice Guidelines Recommend Genetic Testing of All Patients with Breast Cancer (PR Newswire) -7.58%
Sep-21-22 11:09AM	Why Invitae Stock Is Jumping Today (Motley Fool) -5.78%
Sep-20-22 08:30AM	Invitaes Real-World Ciitizen Data Utilized in Praxis Precision Medicines PRAX-222 IND Filing (GlobeNewswire) -6.07%
07:30AM	Invitae's Real-World Ciitizen Data Utilized in Praxis Precision Medicines' PRAX-222 IND Filing (PR Newswire)
Sep-15-22 04:00PM	Leading Clinical Experts Across the U.S. Unite to Support Universal Genetic Testing for all Patients with Cancer (PR Newswire)
Sep-13-22 06:25PM	Why Shares of Invitae Dropped 13% on Tuesday (Motley Fool) -13.00%
Sep-12-22 07:30AM	Invitae and Simons Searchlight Partner to Accelerate Research through Data Sharing (PR Newswire)
Sep-07-22 10:26AM	2 Cathie Wood Stocks That Soared 60% in August (Motley Fool) +11.31%
Sep-06-22 11:18AM	Meme-Stock Mania Is Leaving These Genomics Stocks (TheStreet.com)

Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nussbaum Robert L	Chief Medical Officer	Jun 13	Sale	1.38	7,086	9,757	569,345	Jun 15 04:58 PM
Brida Thomas	See Remarks	Jun 13	Sale	1.38	7,079	9,748	704,087	Jun 15 04:57 PM
Wen Yafei	Chief Financial Officer	May 16	Sale	1.99	43,452	86,600	700,297	May 18 04:17 PM
Knight Kenneth D.	Chief Executive Officer	May 16	Sale	1.20	45,432	54,487	1,671,610	May 18 04:20 PM
Brida Thomas	See Remarks	May 16	Sale	1.20	26,476	31,753	711,166	May 18 04:14 PM
Nussbaum Robert L	Chief Medical Officer	May 16	Sale	1.20	26,476	31,753	576,431	May 18 04:18 PM
WERNER ROBERT F.	Chief Accounting Officer	May 16	Sale	1.20	21,559	25,856	354,748	May 18 04:15 PM
Wen Yafei	Chief Financial Officer	Mar 13	Sale	1.41	2,625	3,701	443,749	Mar 15 04:22 PM
Brida Thomas	See Remarks	Mar 13	Sale	1.41	2,625	3,701	437,642	Mar 15 04:36 PM
Nussbaum Robert L	Chief Medical Officer	Mar 13	Sale	1.41	2,625	3,701	447,907	Mar 15 04:23 PM
Knight Kenneth D.	Chief Executive Officer	Mar 13	Sale	1.41	1,853	2,613	517,042	Mar 15 04:22 PM
George Sean E	Director	Dec 19	Sale	2.08	11,163	23,210	732,677	Dec 20 09:00 PM
George Sean E	Director	Dec 16	Sale	2.04	44,816	91,420	743,840	Dec 20 09:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVTA | Invitae Corp

Upgrade your FINVIZ experience